These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6345323)

  • 1. Functional study of insulin secretion pattern following segmental neoprene-injected pancreatic allograft in insulin-dependent (type 1) diabetic recipients.
    Traeger J; Dubernard JM; Pozza G; Secchi A; Bosi E; Pontiroli AE; Gelet A; Martin X; Touraine JL
    Horm Metab Res Suppl; 1983; (13):63-6. PubMed ID: 6345323
    [No Abstract]   [Full Text] [Related]  

  • 2. Transplantation for the treatment of insulin-dependent diabetes: clinical experience with polymer-obstructed pancreatic grafts using neoprene.
    Dubernard JM; Traeger J; Bosi E; Gelet A; Yafi SE; Devonec M; Piatti PM; Chiesa R; Martin X; Mongin-Long D
    World J Surg; 1984 Apr; 8(2):262-6. PubMed ID: 6375151
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress in segmental neoprene-injected pancreas transplantation. Advantages and disadvantages of using Cyclosporin A.
    Traeger J; Dubernard JM; Bosi E; Gelet A; El Yafi S; Secchi A; Cardozo C; Touraine JL
    Proc Eur Dial Transplant Assoc; 1983; 20():705-10. PubMed ID: 6361763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of metabolic and endocrine function in ten neoprene-injected segmental pancreas allografts at three to 54 months after transplantation, versus preliminary results in nine whole pancrease allografts with enteric diversion.
    Cantarovich D; Traeger J; La Rocca E; Monti LD; Lefrançois N; Cantarovich F; Betuel H; Blanc-Brunat N; Faure JL; Gelet A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2310-3. PubMed ID: 3547926
    [No Abstract]   [Full Text] [Related]  

  • 5. First peak insulin release after intravenous glucose and arginine is maintained for up to 3 years after segmental pancreas transplantation.
    Secchi A; Martinenghi S; Caldara R; La Rocca E; Di Carlo V; Pozza G
    Diabetologia; 1991 Aug; 34 Suppl 1():S53-6. PubMed ID: 1936696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the exocrine function as an aid to of segmental pancreatic transplantation in dogs.
    Dubernard JM; Traeger J; Neyra P
    Biomedicine; 1977 Jun; 27(4):172-4. PubMed ID: 890025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin secretion, insulin action and non-insulin-dependent glucose uptake in pancreas transplant recipients.
    Christiansen E; Tibell A; Võlund A; Rasmussen K; Tydén G; Pedersen O; Christensen NJ; Madsbad S
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1561-9. PubMed ID: 7989456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new method of pancreatic transplantation. 1 - Effects on the dog pancreas of the intraduct injection of neoprene (author's transl)].
    Dubernard JM; Traeger J; Neyra P; Blanc-Brunat N; Ruitton A
    Nouv Presse Med; 1978 Jan; 7(3):173-6. PubMed ID: 351559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine responses of type 1 (insulin-dependent) diabetic patients following successful pancreas transplantation.
    Pozza G; Traeger J; Dubernard JM; Secchi A; Pontiroli AE; Bosi E; Malik MC; Ruitton A; Blanc N
    Diabetologia; 1983 Apr; 24(4):244-8. PubMed ID: 6134651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic segmental pancreas transplantation in diabetic dogs with and without occlusion of the pancreatic duct.
    Lippert H; Lorenz D; Wolff H; Abri O; Kühn F
    Horm Metab Res Suppl; 1983; (13):16-9. PubMed ID: 6345315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with 15 neoprene-injected pancreatic allotransplants.
    Traeger J; Dubernard JM; Ruitton AM; Malik MC; Touraine JL
    Transplant Proc; 1980 Dec; 12(4 Suppl 2):44-50. PubMed ID: 7013204
    [No Abstract]   [Full Text] [Related]  

  • 12. Normalization of insulin sensitivity and glucose homeostasis in type I diabetic pancreas transplant recipients: a 48-month cross-sectional study--a clinical research center study.
    Cottrell DA
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3513-9. PubMed ID: 8855794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts.
    Diem P; Redmon JB; Abid M; Moran A; Sutherland DE; Halter JB; Robertson RP
    J Clin Invest; 1990 Dec; 86(6):2008-13. PubMed ID: 2254456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with 31 pancreatic allografts in man.
    Dubernard JM; Traeger J; Gelet A; Martin X; Pozza G; Secchi A; Bosi E; Touraine JL
    Horm Metab Res Suppl; 1983; (13):59-62. PubMed ID: 6345322
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatic exocrine "burnout" following pancreas transplantation.
    Barone GW; Henry ML; Elkhammas EA; Osei K; Tesi RJ; Ferguson RM
    Transplant Proc; 1992 Jun; 24(3):831-2. PubMed ID: 1376529
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in human neoprene-injected pancreas transplantation: experience with 47 cases.
    Dubernard JM; Traeger J; Bosi E; Secchi A; Piatti PM; Gelet A; El Yafi S; Kamel G; Touraine JL
    Transplant Proc; 1984 Oct; 16(5):1267-9. PubMed ID: 6435297
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autologous heterotopic partial transplantation of the pancreas in the dogs with reference to different drainage methods].
    Abri O; Lippert H; Lorenz D; Wolff H; Kühn F
    Z Exp Chir Transplant Kunstliche Organe; 1986; 19(2):83-93. PubMed ID: 3524042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of the pancreas after intraductal neoprene injection in dogs and diabetic patients treated by pancreatic transplantation.
    Blanc-Brunat N; Dubernard JM; Touraine JL; Neyra P; Dubois P; Paulin C; Traeger J
    Diabetologia; 1983 Aug; 25(2):97-107. PubMed ID: 6354816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreata from pediatric donors restore insulin independence in adult insulin-dependent diabetes mellitus recipients.
    Socci C; Orsenigo E; Santagostino I; Caumo A; Caldara R; Parolini D; Aldrighetti L; Castoldi R; Frasson M; Carvello M; Ghirardelli L; Secchi A; Di Carlo V; Staudacher C
    Transplant Proc; 2010; 42(6):2068-70. PubMed ID: 20692410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin insensitivity and glucose effectiveness in type I diabetic allograft pancreas recipients.
    Osei K; Cottrell DA; Henry ML; Tesi RJ; Ferguson RM; O'Dorisio TM
    Transplant Proc; 1992 Jun; 24(3):828-30. PubMed ID: 1604629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.